New shot aims to stop stubborn hives
NCT ID NCT07166211
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 31 times
Summary
This study tests an experimental drug called CM512 for people with chronic spontaneous urticaria (CSU) — long-lasting hives and itching that don't go away with standard antihistamines. About 48 adults will receive either CM512 or a placebo injection. The main goal is to see if the drug reduces hives and itch scores over 16 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA (CSU) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tianjin Academy of Traditional Chinese Medicine Affiliate Hospital
RECRUITINGTianjin, Tianjin Municipality, China
Conditions
Explore the condition pages connected to this study.